← Open Payments lookup

MATTHEW STROMBERG: Open Payments

NPI 1922888429 · EDINBURG, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,153 in 213 payments from 15 companies in 2025. Trend: 2023 $250 · 2024 $3,360 · 2025 $4,153

Food & beverage: $4,153
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.36$721
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)24$606
Alkermes, Inc.24$495
ABBVIE INC.22$478
Otsuka America Pharmaceutical, Inc.18$404
Corium, LLC19$353
Supernus Pharmaceuticals, Inc.21$273
E.R. Squibb & Sons, L.L.C.15$183
Collegium Pharmaceutical, Inc.8$146
Neurocrine BioSciences, Inc.6$144

Products named: CAPLYTA, UZEDY, VRAYLAR, ARISTADA, Azstarys, REXULTI, Qelbree, AUSTEDO XR.

Industry payments across TX — which companies pay providers there.